NO20003018D0 - Triazinangiogenese-inhibitorer - Google Patents
Triazinangiogenese-inhibitorerInfo
- Publication number
- NO20003018D0 NO20003018D0 NO20003018A NO20003018A NO20003018D0 NO 20003018 D0 NO20003018 D0 NO 20003018D0 NO 20003018 A NO20003018 A NO 20003018A NO 20003018 A NO20003018 A NO 20003018A NO 20003018 D0 NO20003018 D0 NO 20003018D0
- Authority
- NO
- Norway
- Prior art keywords
- triazinangiogenese
- inhibitors
- compounds
- angiogenesis
- exacerbated
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99011997A | 1997-12-12 | 1997-12-12 | |
| US09/209,396 US6150362A (en) | 1997-12-12 | 1998-12-10 | Triazine angiogenesis inhibitors |
| PCT/US1998/026369 WO1999031088A1 (en) | 1997-12-12 | 1998-12-11 | Triazine angiogenesis inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003018D0 true NO20003018D0 (no) | 2000-06-13 |
| NO20003018L NO20003018L (no) | 2000-08-04 |
Family
ID=26904132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003018A NO20003018L (no) | 1997-12-12 | 2000-06-13 | Triazinangiogenese-inhibitorer |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1037886B1 (no) |
| JP (1) | JP2002542144A (no) |
| KR (1) | KR20010032998A (no) |
| CN (1) | CN1290264A (no) |
| AT (1) | ATE239012T1 (no) |
| AU (1) | AU1818599A (no) |
| BG (1) | BG104584A (no) |
| BR (1) | BR9813468A (no) |
| CA (1) | CA2313776A1 (no) |
| DE (1) | DE69814151T2 (no) |
| DK (1) | DK1037886T3 (no) |
| ES (1) | ES2198088T3 (no) |
| HU (1) | HUP0202076A3 (no) |
| IL (1) | IL136339A0 (no) |
| NO (1) | NO20003018L (no) |
| PL (1) | PL344861A1 (no) |
| PT (1) | PT1037886E (no) |
| SK (1) | SK8662000A3 (no) |
| TR (1) | TR200001690T2 (no) |
| WO (1) | WO1999031088A1 (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6943161B2 (en) | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
| FR2804113B1 (fr) * | 2000-01-26 | 2004-06-18 | Lipha | Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique |
| AR029489A1 (es) * | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento |
| JP2004525139A (ja) * | 2001-03-23 | 2004-08-19 | 中外製薬株式会社 | Ｆｌｔ−１リガンド、および血管形成により調節可能な疾患の治療におけるそれらの使用 |
| US6864255B2 (en) | 2001-04-11 | 2005-03-08 | Amgen Inc. | Substituted triazinyl amide derivatives and methods of use |
| AR037233A1 (es) | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
| AR036873A1 (es) | 2001-09-07 | 2004-10-13 | Euro Celtique Sa | Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento |
| US7163943B2 (en) | 2001-09-21 | 2007-01-16 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7112587B2 (en) | 2001-09-21 | 2006-09-26 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7132423B2 (en) | 2001-09-21 | 2006-11-07 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7169785B2 (en) | 2001-09-21 | 2007-01-30 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7173032B2 (en) | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| KR20040088457A (ko) * | 2001-09-21 | 2004-10-16 | 레디 유에스 테라퓨틱스 인코포레이티드 | 신규 트리아진 화합물 제조방법 및 조성물 |
| WO2003032903A2 (en) | 2001-10-12 | 2003-04-24 | New York University | Trisubstituted triazines compounds with antitubulin activity |
| US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
| AU2003245669A1 (en) * | 2002-06-21 | 2004-01-06 | Cellular Genomics, Inc. | Certain aromatic monocycles as kinase modulators |
| US7015227B2 (en) | 2002-06-21 | 2006-03-21 | Cgi Pharmaceuticals, Inc. | Certain amino-substituted monocycles as kinase modulators |
| US20050014753A1 (en) * | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
| US7335770B2 (en) | 2004-03-24 | 2008-02-26 | Reddy U5 Therapeutics, Inc. | Triazine compounds and their analogs, compositions, and methods |
| US7592451B2 (en) | 2005-06-23 | 2009-09-22 | New York University | Treatment for diabetes and obesity as well as method of screening compounds useful for such treatments |
| FR2896161B1 (fr) * | 2006-01-13 | 2008-04-04 | Merck Sante Soc Par Actions Si | Utilisation de derives de triazines pour fabriquer un medicament ayant un effet cicatrisant ou angiogenique. |
| KR100761869B1 (ko) * | 2006-07-07 | 2007-10-04 | 김현기 | 트리아진 유도체 화합물 및 이를 포함하는 암 치료용조성물 |
| DE102007054416A1 (de) | 2007-11-13 | 2009-05-14 | Studiengesellschaft Kohle Mbh | Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind |
| EA020317B1 (ru) * | 2008-05-23 | 2014-10-30 | УАЙТ ЭлЭлСи | ТРИАЗИНЫ КАК ИНГИБИТОРЫ КИНАЗЫ PI3 И mTOR |
| US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| WO2015003360A2 (en) * | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| CN106632000B (zh) * | 2016-12-19 | 2019-04-26 | 湖北工业大学 | 二芳基甲酮化合物在制备抗肿瘤药物中的应用 |
| JP7635474B2 (ja) | 2018-06-06 | 2025-02-26 | プリスティーヌ・エスアーエス | 慢性腎疾患を持つ糖尿病対象を治療する方法 |
| EP3806828A1 (en) | 2018-06-14 | 2021-04-21 | Poxel | Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes |
| CN111686113B (zh) * | 2019-03-15 | 2022-12-30 | 北京大学 | Sonic Hedgehog抑制剂及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2358856C3 (de) * | 1973-11-26 | 1981-05-21 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Stabilisierung wäßriger Formaldehydlösungen |
| DE2919496A1 (de) * | 1979-05-15 | 1980-12-04 | Degussa | Neue bisguanamine |
| KR860001555B1 (ko) * | 1983-10-14 | 1986-10-04 | 가부시기가이샤 히다찌세이사꾸쇼 | 에폭시 수지 조성물 |
| WO1992011247A1 (fr) * | 1990-12-20 | 1992-07-09 | Nippon Shinyaku Co., Ltd. | Composition anticancereuse et compose |
| JPH04300874A (ja) * | 1991-03-29 | 1992-10-23 | Tsumura & Co | 新規２，４−ジアミノ−１，３，５−トリアジン誘導体 |
| JPH04300832A (ja) * | 1991-03-29 | 1992-10-23 | Tsumura & Co | ２，４−ジアミノ−１，３，５−トリアジン誘導体を有 効成分とするロイコトリエン拮抗剤 |
| TW328955B (en) * | 1993-05-14 | 1998-04-01 | Cytec Tech Corp | Process for preparing bis- or tris-carbamate functional 1,3,5-triazines, substantially halogen contamination free crosslinker compositions and new bis-or tris-carbamate functional 1,3,5-triazines |
| DE4423138A1 (de) * | 1994-07-01 | 1996-01-04 | Hoechst Ag | Elastisches Einkomponenten-Epoxidharz-System mit hoher Lagerstabilität |
-
1998
- 1998-12-11 HU HU0202076A patent/HUP0202076A3/hu unknown
- 1998-12-11 TR TR2000/01690T patent/TR200001690T2/xx unknown
- 1998-12-11 SK SK866-2000A patent/SK8662000A3/sk unknown
- 1998-12-11 ES ES98963082T patent/ES2198088T3/es not_active Expired - Lifetime
- 1998-12-11 PT PT98963082T patent/PT1037886E/pt unknown
- 1998-12-11 DE DE69814151T patent/DE69814151T2/de not_active Expired - Fee Related
- 1998-12-11 KR KR1020007006350A patent/KR20010032998A/ko not_active Withdrawn
- 1998-12-11 WO PCT/US1998/026369 patent/WO1999031088A1/en not_active Ceased
- 1998-12-11 CN CN98813592A patent/CN1290264A/zh active Pending
- 1998-12-11 IL IL13633998A patent/IL136339A0/xx unknown
- 1998-12-11 CA CA002313776A patent/CA2313776A1/en not_active Abandoned
- 1998-12-11 AT AT98963082T patent/ATE239012T1/de not_active IP Right Cessation
- 1998-12-11 DK DK98963082T patent/DK1037886T3/da active
- 1998-12-11 PL PL98344861A patent/PL344861A1/xx unknown
- 1998-12-11 JP JP2000539012A patent/JP2002542144A/ja not_active Withdrawn
- 1998-12-11 BR BR9813468-0A patent/BR9813468A/pt not_active IP Right Cessation
- 1998-12-11 AU AU18185/99A patent/AU1818599A/en not_active Abandoned
- 1998-12-11 EP EP98963082A patent/EP1037886B1/en not_active Expired - Lifetime
-
2000
- 2000-06-13 NO NO20003018A patent/NO20003018L/no not_active Application Discontinuation
- 2000-07-06 BG BG104584A patent/BG104584A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20003018L (no) | 2000-08-04 |
| SK8662000A3 (en) | 2001-01-18 |
| EP1037886B1 (en) | 2003-05-02 |
| CN1290264A (zh) | 2001-04-04 |
| TR200001690T2 (tr) | 2001-05-21 |
| DE69814151T2 (de) | 2004-03-25 |
| EP1037886A1 (en) | 2000-09-27 |
| PL344861A1 (en) | 2001-11-19 |
| HUP0202076A3 (en) | 2003-12-29 |
| WO1999031088A1 (en) | 1999-06-24 |
| AU1818599A (en) | 1999-07-05 |
| DK1037886T3 (da) | 2003-08-25 |
| PT1037886E (pt) | 2003-09-30 |
| ATE239012T1 (de) | 2003-05-15 |
| ES2198088T3 (es) | 2004-01-16 |
| BG104584A (bg) | 2001-01-31 |
| DE69814151D1 (de) | 2003-06-05 |
| IL136339A0 (en) | 2001-05-20 |
| CA2313776A1 (en) | 1999-06-24 |
| KR20010032998A (ko) | 2001-04-25 |
| JP2002542144A (ja) | 2002-12-10 |
| BR9813468A (pt) | 2001-11-13 |
| HUP0202076A2 (hu) | 2002-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003018L (no) | Triazinangiogenese-inhibitorer | |
| DE69919397D1 (de) | Thrombin-inhibitoren | |
| DK1257550T3 (da) | Blodplade-ADP-receptor-inhibitor | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| CA2367017A1 (en) | Inhibitors of impdh enzyme | |
| TR200001279T2 (tr) | Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler. | |
| BR0115411A (pt) | Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares | |
| BG104779A (en) | Inhibitors of phospholipase enzymes | |
| JO2372B1 (en) | Source drugs of 4-phenylpyridine derivatives | |
| BR9811099A (pt) | Inibidores de urocinase | |
| ATE289590T1 (de) | Beta-sulfonyl-hydroxamsäuren als matrix- metalloproteinaseinhibitoren | |
| DE69716810D1 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
| CO5261493A1 (es) | Procedimiento y compuestos para la inhibicion de la mrp1 | |
| DE60027144D1 (de) | Hydroxamsäure-derivate | |
| ATE297904T1 (de) | Halo-alkoxycarbonylverbindungen | |
| ATE266029T1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
| DK1080070T3 (da) | Antiangiogent lægemiddel til behandling af cancer, artritis og retinopati | |
| ATE277018T1 (de) | 3,4-dihydrochinolin-derivative als stickstoffmonoxid-synthase (nos) inhibitoren | |
| DK1276722T3 (da) | Naphthamidin-urokinaseinhibitorer | |
| SI1077694T1 (en) | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease | |
| AR013802A1 (es) | Inhibidores de angiogenesis de triazina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |